Vaxcyte, Inc.

PCVX

$68.62

Name : Vaxcyte, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,862,544,896.00

EPSttm : -8.05

Vaxcyte, Inc.

$68.62

3.41%

$2.26

PCVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

9.99

Margin Of Safety %

Put/Call OI Ratio

1.31

EPS Next Q Diff

0.45

EPS Last/This Y

-2.23

EPS This/Next Y

1.23

Price

68.62

Target Price

116.4

Analyst Recom

1.2

Performance Q

16.58

Upside

-515.2%

Beta

1.28

Ticker: PCVX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	PCVX	66.75	1.25	0.97	127533
2026-10-14	PCVX	67.55	1.24	7.07	127849
2026-10-15	PCVX	65.51	1.25	4.44	128184
2026-10-16	PCVX	63.44	1.23	0.30	127630
2026-10-19	PCVX	63.71	1.39	2.23	93546
2026-10-20	PCVX	66.25	1.37	0.27	93716
2026-10-21	PCVX	63.22	1.37	0.17	93467
2026-10-22	PCVX	62.81	1.33	0.49	94748
2026-10-23	PCVX	60.35	1.32	0.79	94962
2026-10-26	PCVX	59.97	1.32	0.81	95047
2026-10-27	PCVX	60.39	1.32	0.13	95224
2026-10-28	PCVX	61.45	1.30	0.69	95857
2026-10-29	PCVX	62.52	1.30	0.78	96019
2026-10-30	PCVX	62	1.30	0.08	96066
2026-11-02	PCVX	60.58	1.30	0.48	96135
2026-11-03	PCVX	60.84	1.30	0.60	96207
2026-11-04	PCVX	65.61	1.31	2.81	96555
2026-11-05	PCVX	61.89	1.32	1.14	97025
2026-11-06	PCVX	63.88	1.32	3.33	97020
2026-11-09	PCVX	67.53	1.32	1.25	96983
2026-11-10	PCVX	66.36	1.31	0.09	96898
2026-11-11	PCVX	68.67	1.31	0.38	96930
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	PCVX	66.80	-37.1	-	-8.20
2026-10-14	PCVX	67.55	-35.3	-	-8.16
2026-10-15	PCVX	65.24	-35.3	-	-8.16
2026-10-16	PCVX	63.60	-35.3	-	-8.16
2026-10-19	PCVX	63.69	-35.3	-	-8.16
2026-10-20	PCVX	63.69	-35.3	-	-8.16
2026-10-21	PCVX	66.26	-35.3	-	-8.16
2026-10-22	PCVX	62.81	-35.3	-	-8.14
2026-10-23	PCVX	60.39	-35.3	-	-8.14
2026-10-26	PCVX	59.94	-35.3	-	-8.14
2026-10-27	PCVX	60.63	-35.3	-	-8.14
2026-10-28	PCVX	61.44	-35.3	-	-8.14
2026-10-29	PCVX	62.62	-35.3	-	-8.14
2026-10-30	PCVX	62.00	-35.3	-	-8.14
2026-11-02	PCVX	60.60	-35.3	-	-8.14
2026-11-03	PCVX	60.84	-35.3	-	-8.14
2026-11-04	PCVX	65.64	-35.3	-	-8.14
2026-11-05	PCVX	61.89	-35.3	-	-8.14
2026-11-06	PCVX	63.88	-9.0	-	-8.14
2026-11-09	PCVX	67.51	-9.0	-	-8.14
2026-11-10	PCVX	66.36	-5.9	-	-7.86
2026-11-11	PCVX	68.62	-5.9	-	-7.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	PCVX	-4.71	1.64	11.89
2026-10-14	PCVX	-4.57	1.64	11.54
2026-10-15	PCVX	-4.46	1.64	11.54
2026-10-16	PCVX	-4.46	1.64	11.54
2026-10-19	PCVX	-4.57	1.68	11.54
2026-10-20	PCVX	-4.57	1.68	11.54
2026-10-21	PCVX	-4.46	1.68	0
2026-10-22	PCVX	-4.46	1.68	11.24
2026-10-23	PCVX	-4.46	1.68	11.24
2026-10-26	PCVX	-4.46	2.30	11.24
2026-10-27	PCVX	-4.46	2.30	9.51
2026-10-28	PCVX	-4.46	2.30	9.51
2026-10-29	PCVX	-4.46	2.30	9.51
2026-10-30	PCVX	-4.46	2.30	9.51
2026-11-02	PCVX	-4.41	2.32	9.51
2026-11-03	PCVX	-4.41	2.32	9.51
2026-11-05	PCVX	-4.54	2.32	9.51
2026-11-06	PCVX	-4.54	2.32	9.51
2026-11-09	PCVX	-4.54	3.15	9.51
2026-11-10	PCVX	-4.54	3.15	9.51
2026-11-11	PCVX	-4.54	3.15	9.99
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.99

Avg. EPS Est. Current Quarter

-1.91

Avg. EPS Est. Next Quarter

-1.54

Insider Transactions

-4.54

Institutional Transactions

3.15

Beta

1.28

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

43.3

Max Drawdown 5-Year %

-76.2

Target Price

116.4

P/E

Forward P/E

PEG

P/S

P/B

4.12

P/Free Cash Flow

EPS

-8.14

Average EPS Est. Cur. Y

-7.86

EPS Next Y. (Est.)

-6.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.66

Return on Equity vs Sector %

-72.5

Return on Equity vs Industry %

-53

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.68

EBIT Estimation

◆ PCVX Healthcare

$68.62

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

8/25

Volume

6/15

Valuation

10/20

TP/AR

2/10

Options

3/10

RSI

59.5

Range 1M

67.6%

Sup Dist

4.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

9/30

Estimates

0/20

Inst/Vol

7/15

Options

6/10

EPS Yr

-39.6%

EPS NY

15.1%

52W%

53.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +69.6% upside

Quality

2/30

Valuation

12/30

Growth

5/25

Stability

9/10

LT Trend

4/5

Upside

+69.6%

Quality

PCVX — P/E HistoricalBiotechnology

Vaxcyte, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 507

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

PCVX

Latest News

—

Caricamento notizie per PCVX…

stock quote shares PCVX – Vaxcyte, Inc. Stock Price stock today

news today PCVX – Vaxcyte, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PCVX – Vaxcyte, Inc. yahoo finance google finance

stock history PCVX – Vaxcyte, Inc. invest stock market

stock prices PCVX premarket after hours

ticker PCVX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PCVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y